Literature DB >> 3985627

Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat.

R A Lubet, R T Mayer, J W Cameron, R W Nims, M D Burke, T Wolff, F P Guengerich.   

Abstract

The O-dealkylation of pentoxyresorufin (7-pentoxyphenoxazone) by rat liver microsomes was examined. The reaction appeared highly specific for certain phenobarbital inducible forms of cytochrome P-450 and was increased 95- to 140-fold by animal pretreatment with phenobarbital (75 mg/kg/day, four ip injections) and approximately 50-fold by Aroclor 1254 (500 mg/kg, one ip injection) while animal pretreatment with 3-methylcholanthrene (50 mg/kg/day, three ip injections) resulted in less than a 2-fold increase over the rate detected in control microsomes. It was observed that this activity, in microsomes for Aroclor-pretreated rats, was dependent on O2 and was inhibited by metyrapone and SKF 525-A, indicative of cytochrome(s) P-450 mediation in the reaction. When antibodies directed against purified cytochrome(s) P-450s were employed to inhibit the pentoxyresorufin O-dealkylation reaction, antibodies to P-450PB-B greatly inhibited the reaction (greater than 90%), while antibodies to P-450PB-C or P-450PB/PCN-E had minimal effects. Assay of hepatic microsomes from rats which were pretreated with varying doses of phenobarbital (0.9-75 mg/kg/day, four ip injections) indicated that while aminopyrine-N-demethylase activity was induced only 2-fold at the maximum dose (75 mg/kg/day), pentoxyresorufin O-dealkylase activity was induced approximately 140-fold at this dose and approximately 4-fold by a dose of phenobarbital as low as 0.9 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985627     DOI: 10.1016/0003-9861(85)90138-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  57 in total

Review 1.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Induction of immunotoxicity in mice by polyhalogenated biphenyls.

Authors:  R A Lubet; B N Lemaire; D Avery; R E Kouri
Journal:  Arch Toxicol       Date:  1986-07       Impact factor: 5.153

3.  Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells.

Authors:  Lawrence H Lash; David A Putt; Hongliang Cai
Journal:  Toxicology       Date:  2007-11-04       Impact factor: 4.221

4.  Physical incorporation of NADPH-cytochrome P450 reductase and cytochrome P450 into phospholipid vesicles using glycocholate and Bio-Beads.

Authors:  James R Reed; Lauren M Brignac-Huber; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

5.  O-dealkylation of resorufin ethers as an indicator of hepatic cytochrome P-450 isoenzyme induction in the cotton rat (Sigmodon hispidus): a method for monitoring environmental contamination.

Authors:  C S Elangbam; C W Qualls; R L Lochmiller
Journal:  Bull Environ Contam Toxicol       Date:  1991-07       Impact factor: 2.151

6.  An evaluation of methods for the reconstitution of cytochromes P450 and NADPH P450 reductase into lipid vesicles.

Authors:  James R Reed; Rusty W Kelley; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2006-01-13       Impact factor: 3.922

7.  Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

Authors:  M Bourdi; D Larrey; J Nataf; J Bernuau; D Pessayre; M Iwasaki; F P Guengerich; P H Beaune
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs.

Authors:  E Rekka; E O Ayalogu; D F Lewis; G G Gibson; C Ioannides
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters.

Authors:  T L Chen; S H Chen; T Y Tai; C C Chao; S S Park; F P Guengerich; T H Ueng
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

10.  Identification of P450 enzymes involved in metabolism of verapamil in humans.

Authors:  H K Kroemer; J C Gautier; P Beaune; C Henderson; C R Wolf; M Eichelbaum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.